Market Update: Gecina Shares and Peer Performance

On Friday, 23 September 2026, Gecina (GFC.PA) experienced a modest uptick, rising 0.89 % during the 24‑hour window that concluded at 04:16 AM Central European Time. The stock is presently priced at approximately €63.85 on major exchanges, with a circulating supply of 74.2 million shares. Gecina’s market capitalization stands at €4.6 billion, and the volume of shares traded in the preceding 24 hours amounted to roughly €13.1 million.

The share price has been under pressure since the close of the previous month, sliding 5.09 % from its earlier level. Over the past 200 trading days, Gecina’s simple moving average is €71.61. The highest price it has reached in the last 52 weeks was €83.45 on 24 October 2025, while the lowest was €58.90 on 5 October 2026.

Peer Performance in the Past 24 Hours

The performance of Gecina’s contemporaries offers context for its recent movement:

  • Nexans (NEX.PA) – + 2.87 % – Current price: €114.90 – Market cap: €5.3 billion – P/E ratio: 28.43

  • Compagnie De L’odet (ODET.PA) – 0.00 % (flat) – Current price: €960.00 – Market cap: €4.1 billion – P/E ratio: 27.33

  • Teleperformance (TEP.PA) – + 3.37 % – Current price: €79.20 – Market cap: €4.6 billion – P/E ratio: 9.93

  • Arkema (AKE.PA) – + 0.36 % – Current price: €54.85 – Market cap: €4.2 billion – P/E ratio: 232.05

  • Elis (ELIS.PA) – + 0.46 % – Current price: €21.82 – Market cap: €5.2 billion – P/E ratio: 14.13

These figures illustrate a mixed landscape: while some peers such as Teleperformance and Nexans are enjoying robust gains, others remain static or exhibit modest increases. Gecina’s slight rise, against the backdrop of its 5.09 % decline since the month’s end, suggests a cautious but incremental recovery as investors reassess the company’s valuation relative to its peers.

Takeaway

Gecina’s performance today signals a gradual re‑engagement from the market, albeit within a broader context of sector volatility. Investors will likely continue to monitor the company’s price trajectory against its 200‑day moving average and the relative valuation metrics of comparable firms. The coming weeks should provide clearer insight into whether the current uptick is an isolated fluctuation or the beginning of a sustained trend toward a more favorable valuation.